Guidelines recommend primary prevention implantable cardioverter defibrillator (PPICD) for left ventricular ejection fraction (LVEF) <35% only after 3 months of optimal medical therapy (OMT) or 6 weeks after acute MI with persistent LVEF dysfunction. A 73-year-old woman presented with decompensated heart failure secondary to ischaemic cardiomyopathy. Severe coronary disease with sufficient dysfunctional myocardial segments on cardiac MRI suggested potential benefit from revascularisation. Following discussion with the heart team, she underwent percutaneous coronary intervention (PCI). PPICD implantation was deferred as per guideline recommendations. However, 20 days post-PCI, the patient died from malignant ventricular arrhythmia captured o...
The major burden of sudden cardiac death (SCD) in patients with heart disease occurs in those with a...
STUDY OBJECTIVE To estimate the proportion of patients eligible for implantable cardioverter defi...
Based on the results of randomized multicenter studies, such as the MADIT I, MADIT II, DINAMIT, and ...
Despite many advances in treatment of myocardial infarction (MI) with percutaneous coronary interven...
Of all patients having an acute myocardial infarction (AMI), 25-35% will die of sudden cardiac death...
Sudden death is a devastating complication of heart failure (HF). Current guidelines recommend an im...
Sudden death is a devastating complication of heart failure (HF). Current guidelines recommend an im...
Context Recently, the implantable cardioverter-defibrillator (ICD) has been promoted for prevention ...
Sudden cardiac death (SCD) due to a ventricular arrhythmia is one of the most common causes of death...
Purpose: Patients with left ventricular ejection fraction (LVEF) ≤30% following myocardial inf...
Background: The highest rate of death is in the first few weeks after myocardial infarction (MI). Ho...
Introduction: In patients with a prior myocardial infarction (MI) but preserved left ventricular (LV...
Results from the DANISH Study (Danish Study to Assess the Efficacy of ICDs in Patients with Non-isch...
Background: Implantable cardioverter-defibrillator (ICD) therapy is the most effective prophylactic ...
Arrhythmic death remains one of the most important causes of mortality after an acute myocardial inf...
The major burden of sudden cardiac death (SCD) in patients with heart disease occurs in those with a...
STUDY OBJECTIVE To estimate the proportion of patients eligible for implantable cardioverter defi...
Based on the results of randomized multicenter studies, such as the MADIT I, MADIT II, DINAMIT, and ...
Despite many advances in treatment of myocardial infarction (MI) with percutaneous coronary interven...
Of all patients having an acute myocardial infarction (AMI), 25-35% will die of sudden cardiac death...
Sudden death is a devastating complication of heart failure (HF). Current guidelines recommend an im...
Sudden death is a devastating complication of heart failure (HF). Current guidelines recommend an im...
Context Recently, the implantable cardioverter-defibrillator (ICD) has been promoted for prevention ...
Sudden cardiac death (SCD) due to a ventricular arrhythmia is one of the most common causes of death...
Purpose: Patients with left ventricular ejection fraction (LVEF) ≤30% following myocardial inf...
Background: The highest rate of death is in the first few weeks after myocardial infarction (MI). Ho...
Introduction: In patients with a prior myocardial infarction (MI) but preserved left ventricular (LV...
Results from the DANISH Study (Danish Study to Assess the Efficacy of ICDs in Patients with Non-isch...
Background: Implantable cardioverter-defibrillator (ICD) therapy is the most effective prophylactic ...
Arrhythmic death remains one of the most important causes of mortality after an acute myocardial inf...
The major burden of sudden cardiac death (SCD) in patients with heart disease occurs in those with a...
STUDY OBJECTIVE To estimate the proportion of patients eligible for implantable cardioverter defi...
Based on the results of randomized multicenter studies, such as the MADIT I, MADIT II, DINAMIT, and ...